Tag: Dr Nicholas Waters

spot_imgspot_img

Ipsen obtains development and commercial rights to mesdopetam

Ipsen and IRLAB have signed a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. Mesdopetam is...